Study of ELU001, a C’Dot drug conjugate (CDC) targeting folate receptor α (FRα) overexpressing solid tumors.Wen Wee, Eliel Bayever, Cesar A. Perez et al.|Journal of Clinical Oncology|2024Cited by 3